Further experiments to investigate the functionality of MHCII in those with the GG genotype will need to be conducted to explore these possibilities, with particular attention to the capacity for expression of α-synuclein-derived peptides, as it is known that individuals with PD possess α-synuclein-specific T cells20. This evidence concerns the gene SNCA and Parkinson disease.